Contact the Desk

Editorial correspondence

Frankly Peptides welcomes precise corrections: a species label that needs tightening, a sample size stated incorrectly, a study design described too strongly, a citation attached to the wrong claim, or a later peer-reviewed result that materially changes the evidence. The easiest notes to evaluate include the page, the exact passage, and a stable source identifier or journal link.

Editorial mailbox: editors@franklypeptides.com

Messages are reviewed for editorial accuracy. A submitted source is checked against the claim it is meant to support; it is not added merely because it reaches a preferred conclusion. Replies may take time, and publication of a suggested change is not guaranteed.

What this mailbox cannot do

This is not a clinical intake line, a supplier directory, or a route to peptide access. The desk cannot evaluate an individual condition, interpret symptoms, recommend a compound, provide a human dose or schedule, assess a personal interaction risk, authenticate a product, or locate a vendor. It also cannot advise an athlete on a specific anti-doping case. Requests to review a commercial product, publish a testimonial, or place sponsored copy are outside the editorial brief.

Questions about personal care belong with a licensed clinician who can examine the full medical context. Questions about sport rules belong with the relevant anti-doping authority. Product-quality concerns belong with appropriate regulators or laboratories. This mailbox stays with the published record: what a paper measured, in which model, and whether the site represented it accurately. When a correction is made, the aim is not to make a compound sound better or worse. The aim is to restore the right species, design, scale, and degree of certainty.